Standout Papers

Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia 2010 2026 2015 2020 1.1k
  1. Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (2010)
    Hagop M. Kantarjian, Neil P. Shah et al. New England Journal of Medicine

Immediate Impact

1 by Nobel laureates 12 from Science/Nature 58 standout
Sub-graph 1 of 20

Citing Papers

Novel strategies to manage CAR-T cell toxicity
2025 Standout
From geroscience to precision geromedicine: Understanding and managing aging
2025 Standout
1 intermediate paper

Works of Sandip Shah being referenced

Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
2010 Standout

Author Peers

Author Last Decade Papers Cites
Sandip Shah 1081 213 860 542 45 1.4k
Saengsuree Jootar 1143 194 896 506 74 1.5k
Sélim Corm 996 186 696 435 43 1.3k
Jiří Mayer 713 153 651 311 44 997
Jeff H. Lipton 800 189 565 285 39 1.1k
Agnès Guerci‐Bresler 1339 230 1121 536 53 1.4k
Jorge Vela‐Ojeda 1078 337 651 390 79 1.5k
Sherry Pierce 674 154 522 210 43 997
G. Alimena 1270 306 830 408 31 1.6k
Pierluigi Rossi Ferrini 650 168 451 202 56 1.1k
Fábio Pires de Souza Santos 697 202 648 246 69 1.2k

All Works

Loading papers...

Rankless by CCL
2026